Applied DNA Sciences Inc (APDN)

[mcsharkey]

CLINICAL TRIAL FINDER - PANCAN
10/11/2019
NOTE: Enrollment in Part 1 is complete. Part 2 is actively enrolling.
[/quote]Rocket! Getting excited about this♥♥[/quote]

		Healthcare 	Family & 	Contact 
 Home   	Providers	Patients	Us	FAQs

CLINICAL TRIAL FINDER
The purpose of this Phase II/III study is to evaluate the safety and efficacy of SM-88 in patients with metastatic pancreatic cancer whose disease has progressed or recurred after two lines of prior systemic therapy.

The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020.


General Information
NCT#: NCT03512756
Study ID: Tyme-88-Panc
Trial Phase: Phase II

Trial Sponsor: Tyme, Inc.
Therapies Used in This Trial: SM-88LINK TO THIS MONTH'S ENROLLEMENT ANNOUNCEMENT[/quote]

GLTUA